Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07400666

Intra-gastrointestinal Monitoring Device (PressureDOT®) and Centurion IAP Monitoring Device Comparison Study: Pivotal Study of Safety and Performance.

Intra-gastrointestinal Monitoring Device (PressureDOT®) and Centurion Intra-abdominal Pressure Monitoring Device Comparison Study: Pivotal Study of Safety and Performance.

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
26 (estimated)
Sponsor
Dotspace Inc. · Industry
Sex
All
Age
22 Years
Healthy volunteers
Not accepted

Summary

The proposed clinical study protocol is intended to establish the safety, utility, and reliability of using a pressure-sensing capsule present in a patient's gastrointestinal tract for monitoring intraabdominal pressure (IAP). Monitoring IAP in critically ill patients is common in patients admitted to the ICU following a wide variety of surgical interventions. It has been reported that approximately 50% of critically ill patients will develop intraabdominal hypertension (IAH; defined as an IAP \>12 mmHg) while in the ICU, which can be life-threatening due to complications resulting from organ dysfunction, organ failure, impaired ventilation and hemodynamic instability. When IAH is persistent and elevated above 20 mmHg the condition is identified as "Abdominal Compartment Syndrome (ACS)", which necessitates close monitoring of patients with IAH in order to reduce the development of ACS. IAP measurements based on technologies employing the bladder, gastric, inferior vena cava, rectal, vaginal and direct intraperitoneal placements have been reported for assessing IAP. However, the gold standard method for monitoring IAP is the use of an intravesical (bladder) Foley catheter manometric technique. PressureDOT® (Dotspace Inc.) is the investigational pressure-sensing capsule that will be assessed in a parallel device clinical study protocol performed in the same patient.

Conditions

Interventions

TypeNameDescription
DEVICEdigital capsuleA digital capsule to monitor intra-gastrointestinal pressure and wirelessly transmit the data to bedside reader for healthcare providers.

Timeline

Start date
2026-07-01
Primary completion
2026-10-30
Completion
2026-11-30
First posted
2026-02-10
Last updated
2026-02-10

Regulatory

Source: ClinicalTrials.gov record NCT07400666. Inclusion in this directory is not an endorsement.